LIGAND PHARMACEUTICALS INCORPORATED Sublease Income
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) reported Sublease Income of $200.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SubleaseIncome · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED sublease income for the quarter ending 2019-12-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED sublease income for the quarter ending 2019-09-30 was $100.00K.
- LIGAND PHARMACEUTICALS INCORPORATED sublease income for the quarter ending 2019-06-30 was $300.00K.
- LIGAND PHARMACEUTICALS INCORPORATED sublease income for the quarter ending 2019-03-31 was $300.00K.
- LIGAND PHARMACEUTICALS INCORPORATED sublease income for fiscal 2025 was $200.00K, a 100.00% increase from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED sublease income for fiscal 2024 was $100.00K, a 66.67% decline from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED sublease income for fiscal 2023 was $300.00K, a 57.14% decline from fiscal 2022.
- LIGAND PHARMACEUTICALS INCORPORATED sublease income for fiscal 2022 was $700.00K, a 75.00% increase from fiscal 2021.
| Period end | Sublease Income 3 month | Sublease Income 6 month | Sublease Income 9 month | Sublease Income 12 month |
|---|---|---|---|---|
| 2025-12-31 | $200.00K 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $100.00K 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $300.00K 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $700.00K 10-K · filed 2024-02-29 | |||
| 2021-12-31 | $400.00K 10-K · filed 2023-02-28 | |||
| 2020-12-31 | $300.00K 10-K · filed 2022-02-28 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $100.00K derived: sum of 2 quarters · filed 2021-02-24 | $400.00K derived: sum of 3 quarters · filed 2021-02-24 | $700.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $400.00K derived: sum of 2 quarters · filed 2019-11-08 | $700.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $300.00K 10-Q · filed 2019-08-08 | $600.00K 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $300.00K 10-Q · filed 2019-05-09 |